以质量求发展，以服务铸品牌

Journal of Nursing ›› 2022, Vol. 29 ›› Issue (19): 25-29.doi: 10.16460/j.issn1008-9969.2022.19.025

Previous Articles     Next Articles

  

  • Received:2022-04-19 Published:2022-11-08

PDF (PC)

321

Like

CLC Number: 

  • R473.74
[1] Oliveira AF, Silva GA, Almeida DM.Application of Botulinum Toxin to Treat Sialorrhea in Amyotrophic Lateral Sclerosis Patients: A Literature Review[J]. Einstein (Sao Paulo),2016,14(3):431-434.DOI:10.1590/S1679-45082016RB3594.
[2] McGeachan AJ, Hobson EV, Al-Chalabi A, et al. A Multicentre Evaluation of Oropharyngeal Secretion Management Practices in Amyotrophic Lateral Sclerosis[J]. Amyotroph Lateral Scler Frontotemporal Degener,2017,18(1/2):1-9. DOI:10.1080/21678421.2016.1221433.
[3] Steffen A, Jost W, Bäumer T, et al.Hypersalivation: Update of the German S2k Guideline (AWMF) in Short Form[J]. J Neural Transm (Vienna),2019,126(7):853-862. DOI:10.1007/s00702-019-02000-4.
[4] Banfi P, Ticozzi N, Lax A, et al.A Review of Options for Treating Sialorrhea in Amyotrophic Lateral Sclerosis[J]. Respir Care,2015,60(3):446-454.DOI:10.4187/respcare.02856.
[5] Garuti G, Rao F, Ribuffo V, et al.Sialorrhea in Patients with ALS: Current Treatment Options[J]. Degener Neurol Neuromuscul Dis,2019,9:19-26. DOI:10.2147/DNND.S168353.
[6] Mcgeachan AJ, Mcdermott CJ.Management of Oral Secretions in Neurological Disease[J]. Pract Neurol, 2017,17(2):96-103. DOI:10.1136/practneurol-2016-001515.
[7] Varley LP, Denieffe S, O'Gorman C, et al. A Systematic Review of Noninvasive and Invasive Sialorrhoea Management[J]. J Clin Nurs,2019,28(23/24):4190-4206. DOI:10.1111/jocn.15009.
[8] Varley LP, Gooney M, Denieffe S, et al.Sialorrhoea Management Practices in Residential Older Adults Care Settings: A Qualitative Study[J]. J Nurs Manag,2021,29(5):989-997. DOI:10.1111/jonm.13236.
[9] 王松灵,窦慧昕,秦力铮,等.流唾症的病因、诊断与治疗[J]. 口腔疾病防治, 2019,27(8):477-484. DOI:10.12016/j.issn.2096-1456.2019.08.001.
[10] 王景刚,贠国俊,李庆云,等.儿童病理性流涎诊疗进展[J]. 中华物理医学与康复杂志,2021,43(3):276-279. DOI:10.3760/cma.j.issn.0254-1424.2021.03.022.
[11] Danel-Brunaud V, Touzet L, Chevalier L, et al.Ethical Considerations and Palliative Care in Patients with Amyotrophic Lateral Sclerosis: A Review[J].Rev Neurol (Paris),2017,173(5):300-307.DOI:10.1016/j.neurol.2017.03.032.
[12] Dash RP, Babu RJ, Srinivas NR.Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics[J]. Clin Pharmacokinet,2018,57(11):1385-1398. DOI:10.1007/s40262-018-0655-4.
[13] Tye CB, Gardner PA, Dion GR, et al.Impact of Fiberoptic Endoscopic Evaluation of Swallowing Outcomes and Dysphagia Management in Neurodegenerative Diseases[J]. Laryngoscope,2021,131(4):726-730.DOI:10.1002/lary.28791.
[14] Mezzedimi C, Vinci E, Giannini F, et al.Correlation Between Dysphonia and Dysphagia Evolution in Amyotrophic Lateral Sclerosis Patients[J]. Logoped Phoniatr Vocol,2021,46(3):118-125. DOI:10.1080/14015439.2020.1771766.
[15] Morgante F, Bavikatte G, Anwar F, et al.The Burden of Sialorrhoea in Chronic Neurological Conditions: Current Treatment Options and the Role of IncobotulinumtoxinA (Xeomin®)[J]. Ther Adv Neurol Disord,2019,12:1756286419888601. DOI:10.1177/1756286419888601.
[16] Driskell LD, York MK, Heyn PC, et al.A Guide to Understanding the Benefits of a Multidisciplinary Team Approach to Amyotrophic Lateral Sclerosis (ALS) Treatment[J]. Arch Phys Med Rehabil, 2019, 100(3):583-586.DOI:10.1016/j.apmr.2018.05.002.
[17] Klavžar P, Koritnik B, Leonardis L, et al.Improvements in The Multidisciplinary Care Are Beneficial for Survival in Amyotrophic Lateral Sclerosis(ALS): Experience from a Tertiary ALS Center[J]. Amyotroph Lateral Scler Frontotemporal Degener, 2020, 21(3/4):203-208. DOI:10.1080/21678421.2020.1746809.
[18] Ichikawa K, Sakuma S, Yoshihara A, et al.Relationships between the Amount of Saliva and Medications in Elderly Individuals[J]. Gerodontology, 2011, 28(2):116-120. DOI:10.1111/j.1741-2358.2009.00358.x.
[19] Kohler PF, Winter ME.A Quantitative Test for Xerostomia. the Saxon Test, an Oral Equivalent of the Schirmer Test[J].Arthritis Rheum,1985,28(10):1128-1132. DOI:10.1002/art.1780281008.
[20] Paracka L, Kollewe K, Klietz M, et al.IncobotulinumtoxinA for Hypersalivation in Patients with Amyotrophic Lateral Sclerosis: An Open-label Single-centre Study[J]. J Neural Transm (Vienna),2019, 126(10):1341-1345. DOI:10.1007/s00702-019-02044-6.
[21] 李超,陈素玲,汤清秋,等.超声引导下A型肉毒毒素注射治疗神经源性吞咽障碍患者流涎症的疗效观察[J].中华物理医学与康复杂志, 2020, 42(11):999-1002. DOI:10.3760/cma.j.issn.0254-1424.2020.11.009.
[22] Rapp D.Management of Drooling[J]. Dev Med Child Neurol,1988,30(1):128-129.DOI:10.1111/j.1469-8749.1988.tb04738.x.
[23] Reddihough D, Johnson H, Staples M, et al.Use of Benzhexol Hydrochloride to Control Drooling of Children with Cerebral Palsy[J]. Dev Med Child Neurol, 1990, 32(11):985-989. DOI:10.1111/j.1469-8749.1990.tb08121.x.
[24] Jongerius PH, van den Hoogen FJ, van Limbeek J, et al. Effect of Botulinum Toxin in the Treatment of Drooling: A Controlled Clinical Trial[J]. Pediatrics,2004,114(3):620-627. DOI:10.1542/peds.2003-1104-L.
[25] Rashnoo P, Daniel SJ.Drooling Quantification: Correlation of Different Techniques[J]. Int J Pediatr Otorhinolaryngol,2015,79(8):1201-1205. DOI:10.1016/j.ijporl.2015.05.010.
[26] Mcgeachan AJ, Hobson EV, Shaw PJ, et al.Developing an Outcome Measure for Excessive Saliva Management in MND and an Evaluation of Saliva Burden in Sheffield[J]. Amyotroph Lateral Scler Frontotemporal Degener,2015,16(1/2):108-113.DOI:10.3109/21678421.2014.951942.
[27] van Hulst K, Lindeboom R, van der Burg J, et al. Accurate Assessment of Drooling Severity with the 5-Minute Drooling Quotient in Children with Developmental Disabilities[J]. Dev Med Child Neurol,2012, 54(12):1121-1126. DOI:10.1111/j.1469-8749.2012.04428.x.
[28] Van Hulst K, Van Der Burg JJ,Jongerius PH,et al. Changes in Severity and Impact of Drooling after Submandibular Gland Botulinum Neurotoxin A Injections in Children with Neurodevelopmental Disabilities[J]. Dev Med Child Neurol,2020,62(3):354-362. DOI:10.1111/dmcn.14391.
[29] Thomas-Stonell N, Greenberg J.Three Treatment Approaches and Clinical Factors in The Reduction of Drooling[J].Dysphagia,1988,3(2):73-78. DOI:10.1007/BF02412423.
[30] Chowdhury A, Mukherjee A, Sinharoy U, et al.Non-motor Features of Amyotrophic Lateral Sclerosis: A Clinic-based Study[J]. Ann Indian Acad Neurol,2021,24(5):745-753. DOI:10.4103/aian.AIAN_51_21.
[31] Kok SE, Erasmus CE, Scheffer ART, et al.Effectiveness of Submandibular Duct Relocation in 91 Children with Excessive Drooling: A Prospective Cohort Study[J]. Clin Otolaryngol,2018,43(6):1471-1477. DOI:10.1111/coa.13188.
[32] Beswick E, Forbes D, Hassan Z, et al.A Systematic Review of Non-Motor Symptom Evaluation in Clinical Trials for Amyotrophic Lateral Sclerosis[J]. J Neurol, 2022,269(1):411-426. DOI:10.1007/s00415-021-10651-1.
[33] Cedarbaum JM, Stambler N, Malta E, et al.The ALSFRS-R: A Revised ALS Functional Rating Scale That Incorporates Assessments of Respiratory Function. BDNF ALS Study Group (Phase III)[J]. J Neurol Sci,1999,169(1/2):13-21. DOI:10.1016/s0022-510x(99)00210-5.
[34] Bakker LA, Schröder CD, van Es MA, et al. Assessment of the Factorial Validity and Reliability of the ALSFRS-R: A Revision of Its Measurement Model[J]. J Neurol, 2017,264(7):1413-1420. DOI:10.1007/s00415-017-8538-4.
[35] Cazzolli PA, Brooks BR, Lewarski JS, et al.Oral Secretion Scale (OSS) Score in Amyotrophic Lateral Sclerosis(ALS) Patients is Associated with Tolerance of Non-invasive Positive Pressure Ventilation(NPPV), Need for Hospice or Transition to Tracheal Positive Pressure Ventilation (TPPV) and Survival[J]. Neurology,2010,74(9):A181.
[36] Abdelnour-Mallet M, Du Montcel ST, Cazzolli PA, et al.Validation of Robust Tools to Measure Sialorrhea in Amyotrophic Lateral Sclerosis: A Study in a Large French Cohort[J]. Amyotroph Lateral Scler Frontotemporal Degener,2013,14(4):302-307. DOI:10.3109/21678421.2012.735238.
[37] Cazzolli PA, Brooks BR, Nakayama Y, et al.The Oral Secretion Scale and Prognostic Factors for Survival in Subjects with Amyotrophic Lateral Sclerosis[J]. Respir Care,2020,65(8):1063-1076. DOI:10.4187/respcare.07005.
[38] Arbouw ME, Movig KL, Koopmann M, et al.Glycopyrrolate for Sialorrhea in Parkinson Disease: A Randomized, Double-blind, Crossover Trial[J]. Neurology, 2010, 74(15):1203-1207. DOI:10.1212/WNL.0b013e3181d8c1b7.
[39] Assouline A, Levy A, Abdelnour-Mallet M, et al.Radiation Therapy for Hypersalivation:A Prospective Study in 50 Amyotrophic Lateral Sclerosis Patients[J].Int J Radiat Oncol Biol Phys,2014,88(3):589-595.DOI:10.1016/j.ijrobp.2013.11.230.
[40] Smith RA, Macklin EA, Myers KJ, et al.Assessment of Bulbar Function in Amyotrophic Lateral Sclerosis: Validation of a Self-report Scale (Center for Neurologic Study Bulbar Function Scale)[J]. Eur J Neurol,2018,25(7):907-e66. DOI:10.1111/ene.13638.
[1] CHEN En-lin, MO Feng-ling, ZHUANG Ze-ming, ZHANG Ming-zhe, ZHOU Jia-kun, HUANG Li-fang, JI Long-fei, ZHANG Li-fang. Assessment tools for unilateral spatial neglect after stroke: a scoping review [J]. Journal of Nursing, 2025, 32(3): 43-49.
[2] CHEN Jian, XIANG Li-jun, LUO Yan-si, CHEN Jian-hui, CUI Yan-li, LIAO Lin, YAN Ming-yu, ZHANG Xiao-mei. Construction of “Internet +” continuous rehabilitation management program for patients with post-stroke dysphagia [J]. Journal of Nursing, 2024, 31(24): 1-6.
[3] ZHOU Chun-xiang, RAO Yuan, CUI Meng-jiao, SHANG Zhi-ying, ZHANG Tian-lan, QIU Xi-chenhui, QIN Yan-ping. Application effect of sensor technology-based intelligent devices in gait rehabilitation of stroke patients: a Meta-analysis [J]. Journal of Nursing, 2024, 31(24): 44-50.
[4] LI Xiao-mei, TAO Ming, LI Qian-Qian, LI Lin-lin, LI Chun. Construction of symptom management theory-based self-management intervention scheme for neurogenic bladder patients [J]. Journal of Nursing, 2024, 31(22): 61-66.
[5] ZHANG Huang-xia, LI Zhuang-miao, LUO Wen-nan, LI Xiu-xia, HUANG Hui-xiang, LIN Ying-xin. Effect of sizi powder jiaozhen yuan-primary points application on hemiplegic shoulder pain in post-stroke patients [J]. Journal of Nursing, 2024, 31(20): 1-7.
[6] GOU Xin-yu, WU Jing, WEI Cui-cui, ZHAN Shui-rong, DU Pei-yun, WU Ai-rong. Influence of neurogenic bowel dysfunction on quality of survival in patients with spinal cord injury: a structural equation analysis [J]. Journal of Nursing, 2024, 31(20): 13-18.
[7] . [J]. Journal of Nursing, 2024, 31(20): 39-44.
[8] SHI Yang, GU Zhi-e, ZHU Tong, YU Jing, WANG Lin. Chain-mediated effects of social network and self-neglect between frailty and cognitive function in elderly patients with ischemic stroke [J]. Journal of Nursing, 2024, 31(17): 40-45.
[9] . [J]. Journal of Nursing, 2024, 31(14): 63-68.
[10] . [J]. Journal of Nursing, 2024, 31(12): 47-53.
[11] . [J]. Journal of Nursing, 2024, 31(10): 29-32.
[12] . [J]. Journal of Nursing, 2024, 31(10): 53-58.
[13] WEN Min, CHEN Bing, ZHOU Yong-ling, LIU Juan, ZHU Xiao-dan. Construction of joint intervention program of cognitive remediation based on mobile health APP for schizophrenia patients [J]. Journal of Nursing, 2024, 31(9): 1-4.
[14] . [J]. Journal of Nursing, 2024, 31(9): 15-19.
[15] LI Ding-ding, WANG Shuai-you, ZHU Shan-shan, GUO Xin, ZHANG Hui-min, WANG Hong-ru, PAN Qin. Supportive care needs assessment tools for stroke patients: a scoping review [J]. Journal of Nursing, 2024, 31(9): 48-53.
Viewed
Full text


Abstract

Cited
  Shared   
No Suggested Reading articles found!